David B. Karpf

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David B. Karpf:

Company Role Class Num Shares Value Price $ Report Date Ownership
LUMOS PHARMA, INC. Chief Medical Officer Common Stock 8,294 $26,582 $3.20 01 Feb 2023 Direct
LUMOS PHARMA, INC. Chief Medical Officer Stock Option (Right to Buy) 12,000 01 Feb 2023 Direct

Insider Reports Filed by David B. Karpf

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LUMO LUMOS PHARMA, INC. 01 Feb 2023 3 +$3,393 4 Chief Medical Officer 03 Feb 2023, 16:02
LUMO LUMOS PHARMA, INC. 01 Sep 2022 1 -$4,862 4 Chief Medical Officer 06 Sep 2022, 16:55
LUMO LUMOS PHARMA, INC. 01 Feb 2022 2 +$4,008 4 Chief Medical Officer 03 Feb 2022, 15:35
LUMO LUMOS PHARMA, INC. 01 Sep 2021 0 $0 3 Chief Medical Officer 02 Sep 2021, 18:39